DeepMed Research

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

Completed

Conditions: Metastatic Castration Resistant Prostate Cancer (mCRPC)
Metastatic Castration Sensitive Prostate Cancer (mCSPC)

Interventions: Drug: degarelix
Drug: abiraterone
Drug: goserelin
Drug: enzalutamide
Drug: leuprorelin
Drug: docetaxel
Drug: triptorelin
Drug: apalutamide
Drug: cabazitaxel
Drug: Radium-223
Drug: Lutetium-177

First Posted Date: 2023-01-26

Last Posted Date: 2024-04-24

Lead Sponsor: Pfizer

Target Recruit Count: 1

Registration Number: NCT05701007

Locations: 🇫🇮
Pfizer, Helsinki, Finland

A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

Recruiting

Conditions: Atopic Dermatitis
Eczema

First Posted Date: 2023-01-19

Last Posted Date: 2025-05-13

Lead Sponsor: Pfizer

Target Recruit Count: 183

Registration Number: NCT05689151

Locations: 🇫🇷
CHU Amiens-Picardie - Site Nord, Amiens, Somme, France
🇫🇷
CHU Besancon - Hopital Jean Minjoz, Besancon, France
🇫🇷
Ch William Morey, Chalon Sur Saone, France

and more 7 locations

A Study to Understand the Long-term Safety and Effects of an Experimental Gene Therapy for Duchenne Muscular Dystrophy.

Phase 3

Active, not recruiting

Conditions: Duchenne Muscular Dystrophy

Interventions: Biological: fordadistrogene movaparvovec

First Posted Date: 2023-01-19

Last Posted Date: 2025-05-13

Lead Sponsor: Pfizer

Target Recruit Count: 6

Registration Number: NCT05689164

Locations: 🇺🇸
Reed Neurological Research Center, Los Angeles, California, United States
🇺🇸
UCLA Children's Heart Center, Los Angeles, California, United States
🇺🇸
UCLA Clinical Lab Services, Los Angeles, California, United States

and more 9 locations

A Study to Learn How the Study Medicine (Ponsegromab) is Changed and Eliminated From Healthy Chinese Adults

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Ponsegromab

First Posted Date: 2023-01-17

Last Posted Date: 2024-09-30

Lead Sponsor: Pfizer

Target Recruit Count: 18

Registration Number: NCT05685264

Locations: 🇨🇳
HuaShan Hospital, Shanghai, Shanghai, China
🇨🇳
Huashan Hospital Fudan University, Shanghai, Shanghai, China

A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Phase 4

Active, not recruiting

Conditions: Acute Lymphoblastic Leukemia

Interventions: Drug: inotuzumab ozogamicin

First Posted Date: 2023-01-17

Last Posted Date: 2025-05-22

Lead Sponsor: Pfizer

Target Recruit Count: 44

Registration Number: NCT05687032

Locations: 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
🇨🇳
Guangzhou First People's Hospital, Guangzhou, Guangdong, China

and more 12 locations

A Study to Compare Two Different Forms of PF-07081532 in Adults Who Are Overweight or Obese

Phase 1

Completed

Conditions: Obesity
Overweight

Interventions: Drug: Formulation A (PF-07081532 20 mg plus 60 mg)
Drug: Formulation B (PF-07081532 80 mg)

First Posted Date: 2023-01-10

Last Posted Date: 2024-08-09

Lead Sponsor: Pfizer

Target Recruit Count: 20

Registration Number: NCT05677867

Locations: 🇺🇸
New Haven Clinical Research Unit, New Haven, Connecticut, United States

A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma

Phase 1

Recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Elranatamab
Drug: Carfilzomib
Drug: Maplirpacept

First Posted Date: 2023-01-09

Last Posted Date: 2025-04-11

Lead Sponsor: Pfizer

Target Recruit Count: 90

Registration Number: NCT05675449

Locations: 🇺🇸
Clinical Research Advisors (Encino Satellite Location), Encino, California, United States
🇺🇸
Clinical Research Advisors (Korea Town Satellite Location), Los Angeles, California, United States
🇺🇸
Clinical Research Advisors (West Hollywood Satellite Location), Los Angeles, California, United States

and more 28 locations

A Study to Understand the Effect of a Study Medicine Called ARV-471 on Dabigatran Etexilate in Healthy Adults

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: ARV-471
Drug: Dabigatran etexilate

First Posted Date: 2023-01-06

Last Posted Date: 2024-08-16

Lead Sponsor: Pfizer

Target Recruit Count: 24

Registration Number: NCT05673889

Locations: 🇧🇪
Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium

A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity Range

Phase 1

Terminated

Conditions: Obesity

Interventions: Drug: Semaglutide
Drug: PF-07081532

First Posted Date: 2023-01-05

Last Posted Date: 2025-01-14

Lead Sponsor: Pfizer

Target Recruit Count: 32

Registration Number: NCT05671653

Locations: 🇺🇸
Anaheim Clinical Trials, LLC, Anaheim, California, United States

A Study to Learn About Recifercept in Patients With Achondroplasia

Completed

Conditions: Achondroplasia

Interventions: Other: Recifercept

First Posted Date: 2022-12-21

Last Posted Date: 2023-07-27

Lead Sponsor: Pfizer

Target Recruit Count: 250

Registration Number: NCT05659719

Locations: 🇺🇸
Pfizer, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy